These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2997417)

  • 1. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
    Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
    J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
    Kudo M; Vera DR; Trudeau WL; Stadalnik RC
    J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography.
    Kwon AH; Matsui Y; Ha-Kawa SK; Kamiyama Y
    Am J Gastroenterol; 2001 Feb; 96(2):541-6. PubMed ID: 11232703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
    Woodle ES; Ward RE; Stadalnik RC; Vera DR
    Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
    Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
    Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-NGA imaging in liver transplantation: preclinical studies.
    Woodle ES; Vera DR; Stadalnik RC; Ward RE
    Surgery; 1987 Jul; 102(1):55-62. PubMed ID: 3296267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m galactosyl-neoglycoalbumin hepatic scintigraphy in fulminant hepatic failure.
    Moragas M; Pavía J; Ginés A; Ros D; Solá M; Huguet M; Pons F; Setoain J
    Clin Nucl Med; 1995 Apr; 20(4):329-33. PubMed ID: 7788990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin.
    Kurtaran A; Müller C; Novacek G; Kaserer K; Mentes M; Raderer M; Pidlich J; Eibenberger K; Angelberger P; Virgolini I
    J Nucl Med; 1997 Dec; 38(12):1912-5. PubMed ID: 9430468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
    Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
    Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
    Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
    J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass.
    Kudo M; Todo A; Ikekubo K; Hino M; Yonekura Y; Yamamoto K; Torizuka K
    Gastroenterol Jpn; 1991 Dec; 26(6):734-41. PubMed ID: 1662653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments on radionuclide hepatic scanning.
    Rothschild MA; Oratz M; Schreiber SS
    Semin Liver Dis; 1982 Feb; 2(1):29-40. PubMed ID: 7051317
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
    Vera DR; Woodle ES; Stadalnik RC
    J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
    Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
    Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
    Virgolini I; Müller C; Klepetko W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
    Br J Cancer; 1990 Jun; 61(6):937-41. PubMed ID: 2164838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic scintigraphy.
    Goldstein HA
    Lab Res Methods Biol Med; 1983; 7():277-87. PubMed ID: 6353107
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic functional scintigraphic imaging with 99mtechnetium galactosyl serum albumin.
    Kubota Y; Kitagawa S; Inoue K; Ha-Kawa SK; Kojima M; Tanaka Y
    Hepatogastroenterology; 1993 Feb; 40(1):32-6. PubMed ID: 8462925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
    Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
    Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass.
    Miki K; Kubota K; Inoue Y; Vera DR; Makuuchi M
    J Nucl Med; 2001 May; 42(5):733-7. PubMed ID: 11337568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant hepatic uptake of Tc-99m NGA and Tc-99m PMT in a patient with hepatoma.
    Aburano T; Shuke N; Yokoyama K; Tonami N; Hisada K; Tanei M; Terada M; Unoura M; Kobayashi K
    Clin Nucl Med; 1992 Oct; 17(10):793-6. PubMed ID: 1330392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.